Press Room >> 2009 Press Releases FOR IMMEDIATE RELEASE GOVERNOR, BARBASH ANNOUNCE $38 MILLION IN 2009 Ohio Research Commercialization Program Biomedical Awards are as follows: Arteriocyte, Inc., located in Cleveland (Cuyahoga County), in collaboration with the Cleveland Clinic, The Ohio State University, and the University of Toledo, was recommended for $4.9 million in funding to further develop and expand their stem cell-based therapeutics. The Arteriocyte system uses stem cell-based technologies to improve outcomes in cardiovascular disease and other conditions. Engineering and Physical Sciences Awards are as follows: Kent Displays, Inc., located in the City of Kent (Portage County), in collaboration with DuPont Teijin Films, Kent State University, University of Akron, and Solomon Systech Ltd., was recommended for $4.9 million in funding to manufacture and market the world’s first color electronic skin for mobile electronic products. Kent Displays’ will utilize its commercially successful ReflexTM liquid crystal-based technology to create a reflective skin to quickly and easily change the color of mobile electronic devices, including cell phones, laptop computers, and MP3 players, without draining power from the device. ###
April 28, 2009
OHIO THIRD FRONTIER RESEARCH COMMMERCIALIZATION PROGRAM FUNDING
Eight Companies Awarded Research Commercialization Funds
Columbus – Governor Ted Strickland and Mark Barbash, Interim Director of the Ohio Department of Development and Chair of the Ohio Third Frontier Commission, today announced that the Commission recommended more-than $38 million in grants through the Ohio Research and Commercialization Program (RCP) to 8 Ohio companies and institutions to support commercialization of new and innovative technologies. The awards are contingent upon State Controlling Board approval.
“The advancement of ideas and applications to produce sustained development of innovative new products has accelerated growth in unique economic sectors in Ohio,” Barbash said. “Advanced materials are being developed in collaboration with world-renowned industry sectors to create growth clusters around our state, bringing economic expansion, field expertise, and good jobs to Ohioans.”
Case Western Reserve University, located in the City of Cleveland (Cuyahoga County), in collaboration with Athersys, the Cleveland Clinic, and AcelleRx Therapeutics was recommended for $5 million in funding to continue operations of the Center for Stem Cell and Regenerative Medicine. This Ohio Third Frontier Wright Center will develop stem cell technology from basic discovery through clinical trials.
ViewRay Inc., located in Oakwood Village (Cuyahoga County), in collaboration with Quality Electrodynamics, Case Western Reserve University, and The Ohio State University was recommended for $5 million in funding to develop an instrument combining a magnetic resonance imaging (MRI) system with a radiotherapy source to better guide radiation to cancerous tumors while minimizing radiation exposure to the healthy, surrounding tissue.
ChanTest Corporation, located in Cleveland (Cuyahoga County), in collaboration with ANALIZA, Inc., was recommended for $4.8 million in funding to expand their range of services and reagents to accelerate pharmaceutical drug discovery. ChanTest is a contract research organization (CRO) that provides services to pharmaceutical and biotech companies in ion channels and G-protein coupled receptors that are the targets of a substantial fraction of all known pharmaceuticals.
The Cleveland Clinic Foundation, headquartered in Northeast Ohio (Cuyahoga County), in collaboration with Simbionix USA Corp. and Astro Medical Devices was recommended for $3.4 million in funding to develop products to help surgeons more accurately place shoulder, hip, and knee joint replacement implants. More accurate placement will help surgeons reduce premature failure of implants, resulting in improved patient outcomes and reduced healthcare costs.
To view a profile of biomedical activity in Northeast Ohio and other developing sectors, click here.
Zyvex Performance Materials, Inc., located in the City of Columbus (Franklin County), in collaboration with PolyOne Corporation, University of Akron, Shawnee State University, University of Dayton Research Institute, National Composite Center, Center for Multifunctional Polymer Nanomaterials and Devices (CMPND) Wright Center of Innovation, Renegade Materials Corporation, Hexion, PolymerOhio, Lockheed Martin, Owens Corning, and Hexcel, was recommended for $4.9 million in funding to further develop and produce carbon nanotubes modified with Zyvex’s unique Kentera technology. The carbon nanotubes will be used to develop advanced composites for lighter, stronger and lower cost products, with potential applications in the marine, sporting goods, aerospace, and high-end automotive industries.
Hyper Tech Research, Inc., located in the City of Columbus (Franklin County), in collaboration with The Ohio State University, Wright Center of Innovation in Biomedical Imaging, RevWires, and Siemens Magnet Technology, Ltd., was recommended for $5 million in funding to build on Hyper Tech’s platform technology of high-field and high-temperature superconductor wire technology. Hyper Tech will utilize magnesium diboride (MgB2) superconducting wire for a commercial size next-generation full body MRI system, which will operate at higher temperatures and will not require the use of liquid helium bath cooling.
Ohio Third Frontier is committed to expanding Ohio’s technological strengths and promoting commercialization that leads to economic prosperity throughout Ohio. Designed to build world-class research programs, nurture early stage companies, and foster technology development that make existing industries more productive, Ohio Third Frontier creates opportunity through innovation.
The Ohio Research and Commercialization Program advances scientifically unique applied research projects that can sustain the development of new innovative products within three years.
Media contacts: Robert Grevey at (614) 466-6619
or the Communications and Marketing Office at (614) 466-2609